Comprehensive loss for Probiodrug in the third quarter of 2016
Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing therapeutic solutions to treat Alzheimer’s disease, has finished the third quarter 2016…
Pharmaceuticals, Biotechnology and Life Sciences
Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing therapeutic solutions to treat Alzheimer’s disease, has finished the third quarter 2016…
Catalyst Pharmaceuticals, a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating …
GENFIT has signed an agreement for a NASH Registry Project
Stada reports financial results for Q3 2016…
Horizon Discovery Group has entered into an Original Equipment Manufacturer (OEM) agreement with CareDx…
ristol-Myers Squibb Company and Infinity Pharmaceuticals have announced a clinical trial collaboration to evaluate Bristol-Myers Squibb’s Opdivo …
AstraZeneca has announced that Jean-Philippe Courtois, a Non-Executive Director, will step down from the Board of AstraZeneca…
Dechra has appointed Lawson Macartney to the Board
Oxford Pharma’s OXPzero Ibuprofen going back into the clinic
Valneva has reported financial results for first nine months of 2016.